Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-infer
about
Innovative public-private partnerships to maximize the delivery of anti-malarial medicines: lessons learned from the ASAQ Winthrop experienceArtemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient dataMonitoring of efficacy and safety of artemisinin-based anti-malarials for treatment of uncomplicated malaria: a review of evidence of implementation of anti-malarial therapeutic efficacy trials in TanzaniaImpact and Lessons Learned from Mass Drug Administrations of Malaria Chemoprevention during the Ebola Outbreak in Monrovia, Liberia, 2014Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, LiberiaThe effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient dataOpen-label, randomized, non-inferiority clinical trial of artesunate-amodiaquine versus artemether-lumefantrine fixed-dose combinations in children and adults with uncomplicated falciparum malaria in Côte d'Ivoire.Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children.Tailoring a Pediatric Formulation of Artemether-Lumefantrine for Treatment of Plasmodium falciparum Malaria.Efficacy and Safety of Artesunate-Amodiaquine versus Artemether-Lumefantrine in the Treatment of Uncomplicated Plasmodium falciparum Malaria in Sentinel Sites across Côte d'Ivoire.Haemoglobin changes and risk of anaemia following treatment for uncomplicated falciparum malaria in sub-Saharan Africa.Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999-2009The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine.Efficacy of Artesunate/Amodiaquine in the Treatment of Uncomplicated Malaria among Children in Ghana.Sustained Effectiveness of a Fixed-Dose Combination of Artesunate and Amodiaquine in 480 Patients with Uncomplicated Plasmodium falciparum Malaria in Côte d'Ivoire.Polymorphisms in the K13 Gene in Plasmodium falciparum from Different Malaria Transmission Areas of Kenya.Drug use in the management of uncomplicated malaria in public health facilities in the Democratic Republic of the Congo.Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis.
P2860
Q21034090-6A76DEAB-4F13-4B02-A5E6-6A80676E6A22Q26783646-57CC1913-E567-4511-A67F-AB33147C1546Q26820807-BCC47BE8-FE57-4ACA-BE00-22F654F6B418Q28553801-45DF7AF7-1FC8-43F6-B9F5-C3C28FC5DA06Q28691509-2D5F03C0-EDE4-46D0-8969-3CEA44C4F192Q30936416-13920BAE-8E98-4A77-9C7A-D0A0BB9FE0F4Q34611124-A55FAAB6-F1D7-4465-8F58-C52047F73A97Q35607844-2D81E314-A834-4B63-891A-403D2CE1A6F8Q35860066-4023DD13-9F9C-4E11-9228-49B92F016230Q35996318-32D9D801-7BBA-482D-92F8-BD7B1D4983BBQ36413462-FC53F3FD-9F69-419E-9C03-07828A7F0C16Q37233322-0D64FDFE-BB26-4248-BCB1-71666ADE64DCQ37703517-5F7A62D9-DE49-47DD-85B7-2EC45D09BA69Q38529669-EC4DE3DC-3851-4DBD-A3C8-0596F66B1C10Q38657672-D6F08E1E-1B8D-4279-ACBF-54B141642A68Q48023049-6F8FD297-D28D-4C2D-BE19-3D82ED98A7F0Q51144485-2D44E10F-81B1-48E1-BFA2-8F671E3381A5Q53686432-3EF2A19F-C3A7-48E3-A723-D039668F98FDQ55449589-B7294381-34BD-42BB-A45B-347B1A8CFF28
P2860
Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-infer
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Efficacy of artesunate-amodiaq ...... pen-label randomized non-infer
@en
Efficacy of artesunate-amodiaq ...... pen-label randomized non-infer
@nl
type
label
Efficacy of artesunate-amodiaq ...... pen-label randomized non-infer
@en
Efficacy of artesunate-amodiaq ...... pen-label randomized non-infer
@nl
prefLabel
Efficacy of artesunate-amodiaq ...... pen-label randomized non-infer
@en
Efficacy of artesunate-amodiaq ...... pen-label randomized non-infer
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Efficacy of artesunate-amodiaq ...... ndomized non-inferiority trial
@en
P2093
Birgit Schramm
Charles S Mazinda
Elizabeth A Ashley
Eric Comte
Gwenaelle Carn
Jean-René Kiechel
Joel J Jones
Loretxu Pinoges
Mehul Dhorda
Parastou Valeh
P2860
P2888
P3181
P356
10.1186/1475-2875-12-251
P407
P577
2013-07-17T00:00:00Z
P5875
P6179
1031206401